Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-04-01 Sale |
2024-04-03 8:47 pm |
Terns Pharmaceuticals Inc. | TERN | Vivo Opportunity LLC Vivo Opportunity Fund Holdings L.P. Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. 10% Owner |
420,663 | $6.6487 | $2,796,859 | 268,573 (Indirect) |
View |
| 2023-12-15 Sale |
2023-12-19 6:00 pm |
IMPEL PHARMACEUTICALS INC | IMPL | Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. 10% Owner |
575,000 | $0.12892 | $74,131 | 280,294 (Indirect) |
View |
| 2023-11-21 Sale |
2023-11-22 6:51 pm |
Bolt Biotherapeutics Inc. | BOLT | Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. Vivo Opportunity LLC Vivo Opportunity Fund Holdings L.P. Vivo Panda LLC Vivo Panda Fund L.P. 10% Owner |
3,400 | $0.9 | $3,060 | 1,559,948 (Indirect) |
View |
| 2023-11-16 Sale |
2023-11-20 9:09 pm |
Bolt Biotherapeutics Inc. | BOLT | Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. Vivo Opportunity LLC Vivo Opportunity Fund Holdings L.P. Vivo Panda LLC Vivo Panda Fund L.P. 10% Owner |
77,843 | $0.92875 | $72,297 | 1,561,405 (Indirect) |
View |
| 2022-12-23 Purchase |
2022-12-23 5:48 pm |
Terns Pharmaceuticals Inc. | TERN | Vivo Opportunity LLC Vivo Opportunity Fund Holdings L.P. Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. 10% Owner |
758,620 | $7.25 | $5,499,995 | 6,657,992 (Indirect) |
View |
| 2022-09-07 Purchase |
2022-09-08 8:00 pm |
Terns Pharmaceuticals Inc. | TERN | Vivo Opportunity LLC Vivo Opportunity Fund Holdings L.P. Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. 10% Owner |
600,000 | $3.6 | $2,160,000 | 5,899,372 (Indirect) |
View |
| 2022-08-12 Purchase |
2022-08-16 8:44 pm |
Terns Pharmaceuticals Inc. | TERN | Vivo Opportunity LLC Vivo Opportunity Fund Holdings L.P. Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. 10% Owner |
2,624,239 | $2.6599 | $6,980,244 | 6,799,372 (Indirect) |
View |
| 2021-04-27 Purchase |
2021-04-29 9:10 pm |
IMPEL NEUROPHARMA INC | IMPL | Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. 10% Owner |
575,000 | $15 | $8,625,000 | 349,674 (Indirect) |
View |
| 2021-02-09 Purchase |
2021-02-09 3:37 pm |
Bolt Biotherapeutics Inc. | BOLT | Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. Vivo Panda Fund L.P. Vivo Panda LLC Vivo Opportunity Fund L.P. Vivo Opportunity LLC 10% Owner |
350,000 | $20 | $7,000,000 | 150,000 (Indirect) |
View |
| 2021-02-09 Sale |
2021-02-09 3:37 pm |
Bolt Biotherapeutics Inc. | BOLT | Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. Vivo Panda Fund L.P. Vivo Panda LLC Vivo Opportunity Fund L.P. Vivo Opportunity LLC 10% Owner |
226 | $20 | $4,520 | 150,000 (Indirect) |
View |
| 2021-02-09 Purchase |
2021-02-09 3:08 pm |
Terns Pharmaceuticals Inc. | TERN | Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. Vivo Opportunity LLC Vivo Opportunity Fund L.P. 10% Owner |
475,000 | $17 | $8,075,000 | 357,353 (Indirect) |
View |
| 2020-10-20 Purchase |
2020-10-20 4:59 pm |
Aligos Therapeutics Inc. | ALGS | Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. 10% Owner |
550,000 | $15 | $8,250,000 | 430,372 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-04-27 Conversion |
2021-04-29 9:10 pm |
N/A N/A |
IMPEL NEUROPHARMA INC | IMPL | Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. 10% Owner |
39,725,922 | $0 | 349,674 (Indirect) |
View |
| 2021-04-27 Conversion |
2021-04-29 9:10 pm |
N/A N/A |
IMPEL NEUROPHARMA INC | IMPL | Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. 10% Owner |
101,456 | $13.5 | 349,674 (Indirect) |
View |
| 2021-04-22 Other |
2021-04-26 6:24 pm |
N/A 2021-12-31 |
IMPEL NEUROPHARMA INC | IMPL | Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. 10% Owner |
1,359,799 | $0 | 1,359,799 (Indirect) |
View |
Ownership |
2021-04-22 9:30 pm |
N/A N/A |
IMPEL NEUROPHARMA INC | IMPL | Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. 10% Owner |
0 | $0 | 2,208,333 (Indirect) |
View |
| 2021-02-09 Exercise |
2021-02-09 3:37 pm |
N/A 2028-07-26 |
Bolt Biotherapeutics Inc. | BOLT | Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. Vivo Panda Fund L.P. Vivo Panda LLC Vivo Opportunity Fund L.P. Vivo Opportunity LLC 10% Owner |
64,319 | $0 | 150,000 (Indirect) |
View |
| 2021-02-09 Exercise |
2021-02-09 3:37 pm |
N/A N/A |
Bolt Biotherapeutics Inc. | BOLT | Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. Vivo Panda Fund L.P. Vivo Panda LLC Vivo Opportunity Fund L.P. Vivo Opportunity LLC 10% Owner |
64,319 | $0.07 | 150,000 (Indirect) |
View |
| 2021-02-09 Conversion |
2021-02-09 3:37 pm |
N/A N/A |
Bolt Biotherapeutics Inc. | BOLT | Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. Vivo Panda Fund L.P. Vivo Panda LLC Vivo Opportunity Fund L.P. Vivo Opportunity LLC 10% Owner |
3,414,343 | $0 | 150,000 (Indirect) |
View |
| 2021-02-09 Conversion |
2021-02-09 3:08 pm |
N/A N/A |
Terns Pharmaceuticals Inc. | TERN | Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. Vivo Opportunity LLC Vivo Opportunity Fund L.P. 10% Owner |
3,426,240 | $0 | 357,353 (Indirect) |
View |
Ownership |
2021-02-04 7:33 pm |
N/A N/A |
Bolt Biotherapeutics Inc. | BOLT | Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. Vivo Panda Fund L.P. Vivo Panda LLC 10% Owner |
0 | $0 | 3,521,517 (Indirect) |
View |
Ownership |
2021-02-04 5:05 pm |
N/A N/A |
Terns Pharmaceuticals Inc. | TERN | Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. 10% Owner |
0 | $0 | 2,200,133 (Indirect) |
View |
| 2020-10-20 Conversion |
2020-10-20 4:59 pm |
N/A N/A |
Aligos Therapeutics Inc. | ALGS | Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. 10% Owner |
2,997,030 | $0 | 430,372 (Indirect) |
View |
Ownership |
2020-10-15 5:17 pm |
N/A N/A |
Aligos Therapeutics Inc. | ALGS | Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. 10% Owner |
0 | $0 | 2,997,030 (Indirect) |
View |